Republic of Korea vs United States of America: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Republic of Korea
95.0%
in 2025
United States of America
95.0%
in 2025
Republic of Korea rank
29th
United States of America rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Republic of Korea
- United States of America
How they compare
Republic of Korea currently reports 95.0% against 95.0% in United States of America, a difference of 0.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was United States of America ahead.
Republic of Korea ranks 29th and United States of America ranks 29th of 194 countries.
Republic of Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Republic of Korea | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.0% | 86.2% | 2.8% | Republic of Korea |
| 2010s | 96.8% | 92.3% | 4.5% | Republic of Korea |
| 2020s | 95.3% | 95.0% | 0.3% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Republic of Korea or United States of America?
- Republic of Korea, at 95.0% against 95.0% in United States of America as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Republic of Korea and United States of America?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and United States of America?
- 26 years are reported by both, from 2000 to 2025.
- How do Republic of Korea and United States of America rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Republic of Korea ranks 29th and United States of America ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.